Patent details

Basic Information

Publication number:

EP1604680

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP050066240

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of botulinum toxin in the treatment of neuralgia pain

French Title of Invention:

Utilisation de la toxine botulinique dans le traitement des douleurs névralgiques

German Title of Invention:

Verwendung von Botulinum Toxin zur Behandlung von neuralgischen Schmerzen

SPC Number:

Dates

Filing date:

11/04/2001

Grant date:

27/01/2010

EP Publication Date:

27/01/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/12/2005

EP B1 Publication Date:

27/01/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/04/2017

Expiration date:

11/04/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/04/2001

 

 

Name:

ALLERGAN INC.

Address:

2525 Dupont Drive, Irvine CA 92612, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

27/01/2010

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Aoki Kei Roger

Address:

United States (US)

2

Name:

Jenkins Stephen

Address:

United States (US)

3

Name:

Cui Minglei

Address:

United States (US)

Priority

Priority Number:

550371

Priority Date:

14/04/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/16;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/04/2016

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages